Bill Text - HB605 (2021)

Relative to the therapeutic cannabis program.


Revision: May 12, 2021, 11:45 a.m.

Sen. Sherman, Dist 24

May 6, 2021

2021-1340s

04/06

 

 

Floor Amendment to HB 605-FN

 

Amend the bill by inserting after section 6 the following and renumbering the original section 7 to read as 9:

 

7  Use of Cannabis for Therapeutic Purposes; Protections.  Amend RSA 126-X:2, IX(c) to read as follows:

(c)  Deliver, transfer, supply, sell, or dispense cannabis and related supplies and educational materials to qualifying patients who have designated the alternative treatment center to provide for them, to designated caregivers on behalf of the qualifying patients who have designated the alternative treatment center, to visiting qualifying patients, or to other alternative treatment centers.

8  Use of Cannabis for Therapeutic Purposes; Alternative Treatment Centers.  Amend RSA 126-X:8, XV(b) to read as follows:

(b)  An alternative treatment center or alternative treatment center agent shall not dispense, deliver, or otherwise transfer cannabis to any person or entity other than:

(1)  A qualifying patient who has designated the relevant alternative treatment center; or

(2)  Such patient's designated caregiver; or

(3)  Another alternative treatment center; or

(4)  A visiting qualifying patient.

2021-1340s

AMENDED ANALYSIS

This bill

 

I.  Adds opioid use disorder as a qualifying medical condition for the purpose of the therapeutic use of cannabis.

 

II.  Amends the definitions of "alternative treatment center" and "therapeutic use" and "visiting qualifying patient" in the therapeutic cannabis statute.

 

III.  Permits out-of-state residents qualified in other jurisdictions to purchase therapeutic cannabis at New Hampshire therapeutic dispensaries.

 

IV.  Requires the department of health and human services to adopt rules regarding an alternative treatment center's verification of a visiting qualifying patient's identification.

 

V.  Permits an alternative treatment center to dispense therapeutic cannabis to a visiting qualifying patient and protects the alternative treatment center from prosecution for such distribution.